
|Articles|September 11, 2015
Kim Statham Ringen on the Importance of Meeting Other Survivors
Author(s)Kim Statham Ringen
Kim Statham Ringen, DVM DACVIM (Oncology), a CURE contributor who is currently surviving stage 4 non-small cell lung cancer, discusses the importance of meeting other cancer survivors.
Advertisement
Kim Statham Ringen, DVM DACVIM (Oncology), a CURE contributor who is currently surviving stage 4 non-small cell lung cancer, discusses the importance of meeting other cancer survivors.
“I know all the statistics — the odds are against me,” Ringen says. “You don’t actually obtain hope until you meet another individual who’s pretty much just like you — same stage, same treatment options — and they’re out four years, five years, six years, seven years.”
Advertisement
Advertisement
Advertisement
Trending on CURE
1
Doctor Outlines Cervical Cancer Care, Side Effects, HPV Prevention
2
FDA to Review New Drug Combo for Previously Treated Metastatic Colorectal Cancer
3
Erleada Shows Survival Advantage in Real-World Study of Metastatic Prostate Cancer
4
Expert Insights: FDA Approval of Lymphir for Cutaneous T-Cell Lymphoma
5




